Cue Biopharma , Inc. (NASDAQ:CUE) is undergoing a significant transformation as it shifts its focus to developing novel biologic therapies for autoimmune diseases. The company's strategic pivot ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...